Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

NCT03165955 is registered in ClinicalTrials.gov with Health Hope Pharma as lead sponsor.

NCT NCT03165955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03165955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients
Lead sponsor
Health Hope Pharma
Phase
Phase 1
Overall status
Completed
Start date
May 9, 2017
Completion date
November 22, 2018
Enrollment
28 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breastcancer